Napromex (Naproxen)

Naproxen, the active ingredient in Napromex, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for oral use. It relieves mild to moderate pain, reduces inflammation in conditions such as rheumatoid arthritis and osteoarthritis, eases dysmenorrhea, treats gout flares and lowers fever in adult patients.

GNH USA supplies Napromex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent product availability and regulatory compliance.

Naproxen is used to manage pain and inflammation across several musculoskeletal and systemic conditions.

- Mild to moderate pain: Provides relief of acute or chronic pain such as headache, toothache, or postoperative discomfort. - Rheumatoid arthritis: Reduces joint inflammation and stiffness, improving mobility and function. - Osteoarthritis: Alleviates pain and swelling in weight‑bearing joints, supporting daily activities. - Dysmenorrhea: Decreases menstrual cramps and associated pelvic pain. - Gout flares: Lowers inflammation and pain during acute gout attacks. - Fever: Helps lower elevated body temperature in febrile states.

Naproxen may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Elevated blood pressure. - Skin rash or itching.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Severe hepatic injury. - Renal impairment or failure. - Anaphylactic or severe allergic reactions. - Cardiovascular events such as myocardial infarction or stroke.

When prescribing or dispensing naproxen, several safety considerations should be observed.

- Assess gastrointestinal risk: evaluate history of ulcers, bleeding or concurrent NSAID use. - Monitor renal function: avoid in patients with severe kidney disease or dehydration. - Check cardiovascular status: use cautiously in those with hypertension, heart failure or prior thrombotic events. - Review hepatic health: limit use if liver disease is present. - Avoid use in late pregnancy: NSAIDs are contraindicated in the third trimester. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Naproxen can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Selective serotonin reuptake inhibitors (SSRIs) or SNRIs: heightened gastrointestinal bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive toxicity to gastrointestinal tract and kidneys. - Lithium: naproxen may raise lithium serum levels, risking toxicity. - Methotrexate (high dose): reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may diminish renal function, especially in volume‑depleted patients. - Diuretics: potential for reduced renal perfusion. - Corticosteroids: increased ulcer risk. - Antihypertensives: possible attenuation of blood pressure control. - Oral hypoglycemics: naproxen may affect glucose control.